First patients test new cancer drug in safety hunt
NCT ID NCT02674152
Summary
This was the first study in humans to test a new cancer drug called BI 836880. It involved 29 patients with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find the highest safe dose of the drug and understand how the body handles it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
INS Curie
Paris, 75248, France
-
Universitätsklinikum Augsburg
Augsburg, 86156, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
Conditions
Explore the condition pages connected to this study.